A novel partial de novo duplication of JARID2 gene causing a neurodevelopmental phenotype

Mol Genet Genomic Med. 2022 Nov;10(11):e2037. doi: 10.1002/mgg3.2037. Epub 2022 Aug 18.

Abstract

Background: Deletions covering the entire or partial JARID2 gene as well as pathogenic single nucleotide variants leading to haploinsufficiency of JARID2 have recently been shown to cause a clinically distinct neurodevelopmental syndrome. Here, we present a previously undescribed partial de novo duplication of the JARID2 gene in a patient displaying features similar to those of patients with JARID2 loss-of-function variants.

Case report: The index patient presents with abnormalities in gross motor skills and speech development as well as neuropsychiatric disorders. The patient has markedly dark infraorbital circles and slightly prominent supraorbital ridges.Whole-genome sequencing and array comparative genomic hybridization revealed a novel disease-causing variant type, a partial tandem duplication of JARID2, covering the exons 1-7. Furthermore, RNA sequencing validated the increased expression of these exons. Expression alterations were also detected in target genes of the PRC2 complex, in which JARID2 acts as an essential member.

Conclusion: Our data add to the variety of different pathogenic variants associated with JARID2 neurodevelopmental syndrome.

Keywords: JARID2; RNA sequencing; de novo; duplication; pathogenic variant; whole genome sequencing.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Comparative Genomic Hybridization
  • Exons
  • Haploinsufficiency*
  • Phenotype